Atila Biosystems Incorporated
Sunnyvale, CA
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 500 Mercury Dr, Sunnyvale, CA 94085, USA
- Website
- atilabiosystems.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Purchase of HPV genotyping assays and testing supplies in support of research efforts for the national cancer… | National Cancer Institute (NIH) | $95,995 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Progress: prevention of cervical cancer using the genotyping ampfire? Screening with same-day treatment | National Cancer Institute (NIH) | $5,031,599 |
Similar vendors
About the company
Atila Biosystems Incorporated is a company that specializes in developing nucleic acid amplification and detection technologies for clinical molecular diagnostics. They provide molecular diagnostic assays, including COVID-19 testing, non-invasive prenatal testing, HPV genotyping, and supplies to support research efforts. Through a prime federal contract award from the Department of Health and Human Services National Institutes of Health National Cancer Institute, Atila Biosystems provided HPV genotyping assays and testing supplies to support research efforts for $95,995. This contract was designated as a Total Small Business set aside. Atila Biosystems has provided goods to prime contractor Leidos Biomedical Research Inc. in the form of IAMP personal station real time fluorescent readers through sub contract awards.
Atila Biosystems received a $5,031,599 federal grant award in 2022 from the Department of Health and Human Services National Institutes of Health National Cancer Institute for a project related to prevention of cervical cancer using the genotyping AMPFire screening with same-day treatment. The project aims to evaluate the performance of the modified AMPFire HPV genotyping test for detection of high-grade precancer and pilot a same-day screen-and-treat strategy using AMPFire and automated visual assessment, an artificial intelligence triage method. Through this grant award, Atila Biosystems is providing goods and services related to cervical cancer screening and triage using their proprietary testing platforms.
SBA capabilities narrative
Atila BioSystems, located in Sunnyvale, CA, is a leading biotechnology company specializing in molecular diagnostics. We provide rapid, cost-effective, and highly sensitive molecular testing solutions. Our proprietary, scalable technology enables molecular testing for infectious diseases, cancer screening, and genetic disorders, optimizing workflows for clinical, research, and public health laboratories.Atila's products are distributed globally, with expertise in regulatory compliance and custom assay development. Our core offerings include high-throughput and point-of-care diagnostics, lab automation for increased efficiency, and OEM/private-label solutions.
Key products in our portfolio include the PS 96 portable PCR instrument, HPV and pathogen detection panels, and customized reagent kits. We serve hospitals, clinical labs, government agencies, and pharmaceutical research institutions, providing comprehensive technical and regulatory support to ensure seamless product adoption.
Quick answers
Is Atila Biosystems Incorporated registered in SAM.gov?
Yes. Atila Biosystems Incorporated's SAM.gov registration is active through November 24, 2026.
What is Atila Biosystems Incorporated's CAGE code?
Atila Biosystems Incorporated's CAGE code is 7GYU4, and its Unique Entity ID (UEI) is YRMLK9B1GHM4.
What is Atila Biosystems Incorporated's most recent federal award?
Atila Biosystems Incorporated's most recent federal grant award is Progress: prevention of cervical cancer using the genotyping ampfire? Screening with same-day treatment (R44CA272177), from National Cancer Institute (NIH), on September 5, 2022.
On GovTribe
See Atila Biosystems Incorporated's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors